162 related articles for article (PubMed ID: 11502538)
1. Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.
Lindsten K; Uhlíková T; Konvalinka J; Masucci MG; Dantuma NP
Antimicrob Agents Chemother; 2001 Sep; 45(9):2616-22. PubMed ID: 11502538
[TBL] [Abstract][Full Text] [Related]
2. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
Majerová-Uhlíková T; Dantuma NP; Lindsten K; Masucci MG; Konvalinka J
J Clin Virol; 2006 May; 36(1):50-9. PubMed ID: 16527535
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a new cell line inducibly expressing HIV-1 protease for performing safe and highly sensitive screening of HIV protease inhibitors.
Fuse T; Watanabe K; Kitazato K; Kobayashi N
Microbes Infect; 2006 Jun; 8(7):1783-9. PubMed ID: 16815068
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic activity of human immunodeficiency virus type 1 protease heterologous fusion proteins in mammalian cells.
Arrigo SJ; Haines JK; Huffman KM
DNA Cell Biol; 1995 Jan; 14(1):15-23. PubMed ID: 7832989
[TBL] [Abstract][Full Text] [Related]
5. Selective and facile assay of human immunodeficiency virus protease activity by a novel fluorogenic reaction.
Yu Z; Kabashima T; Tang C; Shibata T; Kitazato K; Kobayashi N; Lee MK; Kai M
Anal Biochem; 2010 Feb; 397(2):197-201. PubMed ID: 19852926
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
7. Development of A Fission Yeast Cell-Based Platform for High Throughput Screening of HIV-1 Protease Inhibitors.
Benko Z; Zhang J; Zhao RY
Curr HIV Res; 2019; 17(6):429-440. PubMed ID: 31782368
[TBL] [Abstract][Full Text] [Related]
8. A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors.
Buzon MJ; Erkizia I; Pou C; Minuesa G; Puertas MC; Esteve A; Castello A; Santos JR; Prado JG; Izquierdo-Useros N; Pattery T; Van Houtte M; Carrasco L; Clotet B; Ruiz L; Martinez-Picado J
J Antimicrob Chemother; 2012 Jan; 67(1):32-8. PubMed ID: 21994909
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
Wu X; Liu H; Xiao H; Conway JA; Kappes JC
J Virol; 1996 Jun; 70(6):3378-84. PubMed ID: 8648668
[TBL] [Abstract][Full Text] [Related]
10. Protocol for a mammalian cell-based assay for monitoring the HIV-1 protease activity.
Rajakuberan C; Hilton BJ; Wolkowicz R
Methods Mol Biol; 2012; 903():393-405. PubMed ID: 22782834
[TBL] [Abstract][Full Text] [Related]
11. GFP:HIV-1 protease production and packaging with a T4 phage expression-packaging processing system.
Mullaney JM; Black LW
Biotechniques; 1998 Dec; 25(6):1008-12. PubMed ID: 9863054
[TBL] [Abstract][Full Text] [Related]
12. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cellular HIV-1 protease activity by lysyl-tRNA synthetase.
Guo F; Gabor J; Cen S; Hu K; Mouland AJ; Kleiman L
J Biol Chem; 2005 Jul; 280(28):26018-23. PubMed ID: 15888436
[TBL] [Abstract][Full Text] [Related]
14. Bioluminescence detection of proteolytic bond cleavage by using recombinant aequorin.
Deo SK; Lewis JC; Daunert S
Anal Biochem; 2000 May; 281(1):87-94. PubMed ID: 10847614
[TBL] [Abstract][Full Text] [Related]
15. A novel high throughput screening assay for HCV NS3 serine protease inhibitors.
Berdichevsky Y; Zemel R; Bachmatov L; Abramovich A; Koren R; Sathiyamoorthy P; Golan-Goldhirsh A; Tur-Kaspa R; Benhar I
J Virol Methods; 2003 Feb; 107(2):245-55. PubMed ID: 12505640
[TBL] [Abstract][Full Text] [Related]
16. Visualization of human immunodeficiency virus protease inhibition using a novel Förster resonance energy transfer molecular probe.
Jin S; Ellis E; Veetil JV; Yao H; Ye K
Biotechnol Prog; 2011 Jul; 27(4):1107-14. PubMed ID: 21584951
[TBL] [Abstract][Full Text] [Related]
17. Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein.
Pluymers W; Cherepanov P; Schols D; De Clercq E; Debyser Z
Virology; 1999 Jun; 258(2):327-32. PubMed ID: 10366569
[TBL] [Abstract][Full Text] [Related]
18. Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli.
Dautin N; Karimova G; Ullmann A; Ladant D
J Bacteriol; 2000 Dec; 182(24):7060-6. PubMed ID: 11092869
[TBL] [Abstract][Full Text] [Related]
19. A recombinant fusion protein-based, fluorescent protease assay for high throughput-compatible substrate screening.
Bozóki B; Gazda L; Tóth F; Miczi M; Mótyán JA; Tőzsér J
Anal Biochem; 2018 Jan; 540-541():52-63. PubMed ID: 29122614
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Vif-derived peptide inhibits drug-resistant HIV proteases.
Blumenzweig I; Baraz L; Friedler A; Danielson UH; Gilon C; Steinitz M; Kotler M
Biochem Biophys Res Commun; 2002 Apr; 292(4):832-40. PubMed ID: 11944889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
